Rhythm Pharmaceuticals’ obesity drug cuts BMI by up to 18.8% in two-year trial

The Hindu Business Line - Nov 17, 2026

Long-term trial findings presented at ObesityWeek 2026 showed sustained reductions in body mass index among patients receiving the therapy.

Read full article

More News